Gainesville, FL, United States of America

Lei Wang

This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Wang. Retrieved from https://idiyas.com/inventor/lei-wang-0a0bwgup

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lei Wang - Innovator in Nuclear Receptor Modulation

Introduction

Lei Wang is an accomplished inventor based in Gainesville, FL (US). He has made significant contributions to the field of therapeutic agents, particularly in the modulation of nuclear receptors. His work focuses on addressing diseases and disorders where modulation of these receptors is crucial.

Latest Patents

Lei Wang holds a patent titled "Modulators of Nuclear Receptor Subfamily 4 Group A Member 1 (NR4A1) and uses thereof." This patent describes modulators of NR4A1 and their potential applications as therapeutic agents for various diseases, including cancer. His innovative approach aims to provide new treatment options for conditions where NR4A1 modulation is implicated.

Career Highlights

Wang is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies in oncology and other related fields.

Collaborations

Lei Wang collaborates with Weizhou Zhang, who is also a prominent figure in the research community. Their partnership enhances the scope and depth of their research initiatives.

Conclusion

In summary, Lei Wang is a notable inventor whose work in nuclear receptor modulation holds promise for advancing therapeutic options for diseases like cancer. His contributions to the field are significant and continue to inspire further research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…